These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 17052870

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The production of 'aerodynamically equivalent' drug and excipient inhalable powders using a novel fractionation technique.
    Taki M, Marriott C, Zeng XM, Martin GP.
    Eur J Pharm Biopharm; 2011 Feb; 77(2):283-96. PubMed ID: 21185373
    [Abstract] [Full Text] [Related]

  • 23. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
    Li X, Vogt FG, Hayes D, Mansour HM.
    Eur J Pharm Sci; 2014 Feb 14; 52():191-205. PubMed ID: 24215736
    [Abstract] [Full Text] [Related]

  • 24. Physical characteristics and aerosol performance of naringin dry powders for pulmonary delivery prepared by spray-drying.
    Sansone F, Aquino RP, Del Gaudio P, Colombo P, Russo P.
    Eur J Pharm Biopharm; 2009 May 14; 72(1):206-13. PubMed ID: 18996478
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
    Minne A, Boireau H, Horta MJ, Vanbever R.
    Eur J Pharm Biopharm; 2008 Nov 14; 70(3):839-44. PubMed ID: 18620052
    [Abstract] [Full Text] [Related]

  • 27. The influence of formulation components on the aerosolisation properties of spray-dried powders.
    Rabbani NR, Seville PC.
    J Control Release; 2005 Dec 10; 110(1):130-40. PubMed ID: 16226334
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate.
    Learoyd TP, Burrows JL, French E, Seville PC.
    Eur J Pharm Biopharm; 2008 Feb 10; 68(2):224-34. PubMed ID: 17560772
    [Abstract] [Full Text] [Related]

  • 31. Investigation of the physical properties of spray-dried stabilised lysozyme particles.
    Liao YH, Brown MB, Quader A, Martin GP.
    J Pharm Pharmacol; 2003 Sep 10; 55(9):1213-21. PubMed ID: 14604464
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Insulin-micro- and nanoparticles for pulmonary delivery.
    Klingler C, Müller BW, Steckel H.
    Int J Pharm; 2009 Jul 30; 377(1-2):173-9. PubMed ID: 19446621
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Spray-dried carrier-free dry powder tobramycin formulations with improved dispersion properties.
    Pilcer G, Vanderbist F, Amighi K.
    J Pharm Sci; 2009 Apr 30; 98(4):1463-75. PubMed ID: 18752304
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Fabrication of inhalable spore like pharmaceutical particles for deep lung deposition.
    Shen ZG, Chen WH, Jugade N, Gao LY, Glover W, Shen JY, Yun J, Chen JF.
    Int J Pharm; 2012 Jul 01; 430(1-2):98-103. PubMed ID: 22486960
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.